Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tamoxifen Citrate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase I/ Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : DARE-VVA1 (tamoxifen) is a small molecule vaginal insert acting as an Estrogen receptor modulator, which is being investigated for the treatment of moderate to severe dyspareunia.
Brand Name : DARE-VVA1
Molecule Type : Small molecule
Upfront Cash : Not Applicable
December 07, 2023
Lead Product(s) : Tamoxifen Citrate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I/ Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?